Triatomic Management LP Guardant Health, Inc. Transaction History

Triatomic Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$21.58 - $29.5 $43,160 - $59,000	-2,000 Reduced 20.0%	8,000 $216,000
Q3 2023 Nov 03, 2023	SELL	$25.8 - $39.97 $258,000 - $399,700	-10,000 Reduced 50.0%	10,000 $296,000
Q2 2023 Aug 14, 2023	SELL	$20.94 - $38.01 $315,607 - $572,886	-15,072 Reduced 42.97%	20,000 $716,000
Q1 2023 May 03, 2023	BUY	$22.92 - $33.76 $803,850 - $1.18 Million	35,072 New	35,072 $822,000
Q2 2022 Aug 12, 2022	SELL	$28.82 - $77.35 $838,575 - $2.25 Million	-29,097 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$48.25 - $100.49 $120,625 - $251,225	2,500 Added 9.4%	29,097 $1.93 Million
Q4 2021 Feb 14, 2022	BUY	$88.71 - $120.43 $2.36 Million - $3.2 Million	26,597 New	26,597 $2.66 Million

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.34B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Triatomic Management LP, based on Form 13F filings with the SEC.

Stay updated on Triatomic Management LP with notifications on news.